Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESRRA | P11474 | 13/20 | 0.62 |
| ▸ | ESRRB | O95718 | 1/20 | 0.62 |
| ▸ | ESR1 | P03372 | 1/20 | 0.62 |
| ▸ | ESRRG | P62508 | 1/20 | 0.62 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | VHL | P40337 | 1/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL648615 | 1.00 | ESRRA (0.62) | ESRRAESRRBESR1ESRRGESR2 | |
| SCHEMBL651323 | 0.90 | ESRRA (0.58) | ESRRAESRRBESR1ESRRGESR2 | |
| SCHEMBL648904 | 0.90 | ESRRA (0.58) | ESRRAESRRBESR1ESRRGESR2 | |
| SCHEMBL649112 | 0.90 | ESRRA (0.58) | ESRRAESRRBESR1ESRRGESR2 | |
| SCHEMBL649113 | 0.90 | ESRRA (0.58) | ESRRAESRRBESR1ESRRGESR2 | |
| SCHEMBL10153083 | 0.90 | ESRRA (0.48) | ESRRAESRRBESR1ESRRGESR2 | |
| SCHEMBL26508835 | 0.88 | ESRRA (0.68) | ESRRAESRRBESR1ESRRGESR2 | |
| SCHEMBL648125 | 0.88 | ESRRA (0.63) | ESRRAESRRBESR1ESRRGESR2 | |
| SCHEMBL648126 | 0.88 | ESRRA (0.63) | ESRRAESRRBESR1ESRRGESR2 | |
| SCHEMBL648940 | 0.88 | ESRRA (0.63) | ESRRAESRRBESR1ESRRGESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119669-B2 | Substituted phenoxy N-alkylated thiazolidinediones as estrogen related receptor-α modulators | JANSSEN PHARMACEUTICA N.V. (BE) | 2012-02-21 | — | — | US | claimed |
| EP-2132188-B1 | SUBSTITUTED PHENOXY N-ALKYLATED THIAZOLEDINEDIONE AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2011-12-14 | — | — | EP | claimed |
| EP-2132188-A2 | SUBSTITUTED PHENOXY N-ALKYLATED THIAZOLEDINEDIONE AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS | Janssen Pharmaceutica N.V. (BE) | 2009-12-16 | — | — | EP | claimed |
| US-20080286265-A1 | SUBSTITUTED PHENOXY N-ALKYLATED THIAZOLIDINEDIONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-11-20 | — | — | US | claimed |
| WO-2008109731-A2 | SUBSTITUTED PHENOXY N-ALKYLATED THIAZOLEDINEDIONE AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS | JASSEN PHARMACEUTICA N.V. (BE) | 2008-09-12 | — | — | WO | claimed |
| CN-118176429-A | LCA-based battery management method, server and computer program thereof | 安端态有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-117794779-A | Systems, methods, and devices for fault detection of one or more energy storage devices | 泰坦先进能源解决方案公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117698448-A | Contactor operation monitoring for multi-voltage vehicle operation | 通用汽车环球科技运作有限责任公司 | 2024-03-15 | — | — | CN | disclosed |
| US-20240083291-A1 | CONTACTOR OPERATION MONITORING FOR MULTI-VOLTAGE VEHICLE OPERATION | GM Global Technology Operations LLC | 2024-03-14 | — | — | US | disclosed |
| EP-4330075-A2 | SYSTEMS, METHODS, AND DEVICES FOR FAILURE DETECTION OF ONE OR MORE ENERGY STORAGE DEVICES | Titan Advanced Energy Solutions, Inc. (US) | 2024-03-06 | — | — | EP | disclosed |
| US-20240047979-A1 | MULTI-VOLTAGE VEHICLE OPERATION | GM Global Technology Operations LLC | 2024-02-08 | — | — | US | disclosed |
| US-11863005-B2 | Power electronics-based battery management | Clenera, LLC (US) | 2024-01-02 | — | — | US | disclosed |
| US-20120108571-A1 | SUBSTITUTED PHENOXY N-ALKYLATED THIAZOLIDINEDIONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS | GAUL MICHAEL (US) | 2012-05-03 | — | — | US | disclosed |
| US-8119669-B2 | Substituted phenoxy N-alkylated thiazolidinediones as estrogen related receptor-α modulators | JANSSEN PHARMACEUTICA N.V. (BE) | 2012-02-21 | — | — | US | disclosed |
| EP-2132188-B1 | SUBSTITUTED PHENOXY N-ALKYLATED THIAZOLEDINEDIONE AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2011-12-14 | — | — | EP | disclosed |
| US-20110298288-A1 | ENERGY STORAGE SYSTEM | Hanwha Solutions Corporation (KR) | 2011-12-08 | — | — | US | disclosed |
| EP-2393153-A1 | Energy storage system | Samsung SDI Co., Ltd. (KR) | 2011-12-07 | — | — | EP | disclosed |
| EP-2132188-A2 | SUBSTITUTED PHENOXY N-ALKYLATED THIAZOLEDINEDIONE AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS | Janssen Pharmaceutica N.V. (BE) | 2009-12-16 | — | — | EP | disclosed |
| US-20080286265-A1 | SUBSTITUTED PHENOXY N-ALKYLATED THIAZOLIDINEDIONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-11-20 | — | — | US | disclosed |
| WO-2008109731-A2 | SUBSTITUTED PHENOXY N-ALKYLATED THIAZOLEDINEDIONE AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS | JASSEN PHARMACEUTICA N.V. (BE) | 2008-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108571-A1 | SUBSTITUTED PHENOXY N-ALKYLATED THIAZOLIDINEDIONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS | ESR2, ESRRA, ESRRG | ESRRA 2/4885ESRRB 4/4885ESR1 7/4885 |
| US-20080286265-A1 | SUBSTITUTED PHENOXY N-ALKYLATED THIAZOLIDINEDIONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS | ESR2, ESRRA, ESRRG | ESRRA 2/4885ESRRB 4/4885ESR1 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.